Attached files
| file | filename |
|---|---|
| 10-K - CAPRICOR THERAPEUTICS, INC. | v214527_10k.htm |
| EX-31.1 - CAPRICOR THERAPEUTICS, INC. | v214527_ex31-1.htm |
| EX-23.1 - CAPRICOR THERAPEUTICS, INC. | v214527_ex23-1.htm |
| EX-31.2 - CAPRICOR THERAPEUTICS, INC. | v214527_ex31-2.htm |
| EX-32.1 - CAPRICOR THERAPEUTICS, INC. | v214527_ex32-1.htm |
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Nile Therapeutics, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:
(1) the Annual Report on Form 10-K of the Company for the year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 14, 2011
|
/s/ Daron Evans
|
|
Name: Daron Evans
|
|
Title: Chief Financial Officer
|